Fibrin glue containing fibroblast growth factor type 1 and heparin decreases platelet deposition

American Journal of Surgery

Volumn 174, Issue 2, 1997, Pages 188-192

  Zarge, Joseph I ^a,b   Husak, Vicki ^b   Huang, Peter ^b   Greisler, Howard P ^a,b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b HINES VA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN GLUE; FIBROBLAST GROWTH FACTOR; HEPARIN; POLITEF;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTERY INJURY; BYPASS SURGERY; CAROTID ARTERY; CONFERENCE PAPER; CONTROLLED STUDY; ENDARTERECTOMY; FEMORAL ARTERY; HEPARINIZATION; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

ANIMALS; ANTICOAGULANTS; BALLOON DILATATION; DOGS; ENDOTHELIUM, VASCULAR; FIBRIN TISSUE ADHESIVE; FIBROBLAST GROWTH FACTORS; HEPARIN; PLATELET AGGREGATION;

EID: 0030822691     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)00090-1     Document Type: Conference Paper

References (14)

1. Hertzer NR. Early complication of carotid endarterectomy: incidence, diagnosis, and management. In: Moore WS, ed. Surgery for Cerebrovascular Disease. 2nd ed. Philadelphia: WB Saunders; 1996:443-457.
2. Clowes AW. Pathologic intimai hyperplasia as a response to vascular injury and reconstruction. In: Rutherford RB, ed. Vascular Surgery. 4th ed. Philadelphia: WB Saunders; 1995:285-293.
3. Mcbride K, Callow AD. Recurrent stenosis after carotid endarterectomy. In: Bernhard VM, Towne JB, eds. Complications in Vascular Surgery. New York: Grune and Stratton; 1980:259.
4. Taylor RR, Gibbons FA, Cope GD, et al. Effects of low-dose aspirin on restenosis after coronary angioplasty. Am J Card. 1991;68(9):874-878.
5. Gray JL, Kang SS, Zenni GC, et al. FGF-1 affixation stimulates ePTFE endothelialization without intimal hyperplasia. J Surg Res. 1994;57:596.
6. Greisler HP, Cziperle DJ, Kim DU, et al. Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment. Surgery. 1992;112:244-255.
7. Gosselin C, Ren D, Ellinger J, Greisler HP. In vivo platelet deposition on polytetrafluoroethylene coated with fibrin glue containing fibroblast growth factor 1 and heparin in a canine model. Am J Surg. 1995;170:126-130.
8. Zarge JI, Huang P, Husak V, et al. Fibrin glue containing FGF-1 and heparin with autologous EC reduces intimal hyperplasia in a canine artery balloon injury model. J Vasc Surg. 1997;25:840-849.
9. Kang S, Gosselin C, Ren D, Greisler HP. Selective stimulation of endothelial cell proliferation with inhibition of smooth cell proliferation by FGF-1 plus heparin delivered from fibrin glue suspensions. Surgery. 1995;118:280-287.
10. Dumanian GA, Dascombe W, Hong C, et al. A new photopolymerizable blood vessel glue that seals human vessel anastomoses without augmenting thrombogenicity. Plast Reconstr Surg. 1995;95:901.
11. Zarge JI, Gosselin C, Huang P, et al. Platelet deposition on ePTFE grafts coated with fibrin glue with or without FGF-1 and heparin. J Surg Res. 1997;67:4-8.
12. Griesler HP, Losak JJ, Steinan SJ, et al. Effects of class I heparin binding growth factor and fibronectin on platelet adhesion and aggregation. J Vasc Surg. 1990;11(5):665-674.
13. Greisler HP, Gosselin C, Ren D, et al. Biointeractive polymers and tissue engineered blood vessels. Biomaterials. 1996:7:329-336.
14. Sterpetti AV, Schults RD, Baily RT. Endothelial cell seeding after carotid endartectomy in a canine model reduces platelet uptake. Eur J Vasc Surg. 1992;6:390-394.